Frontiers in radiotherapy for early-stage invasive breast cancer. - Wikidata - wikimedia - TriplyDB

Frontiers in radiotherapy for early-stage invasive breast cancer.

Frontiers in radiotherapy for early-stage invasive breast cancer.

http://www.wikidata.org/entity/Q34124291

about

Hypofractionated whole breast irradiation: new standard in early breast cancer after breast-conserving surgery Emerging Role of Hypofractionated Radiotherapy with Simultaneous Integrated Boost in Modern Radiotherapy of Breast Cancer Data-Based Radiation Oncology: Design of Clinical Trials in the Toxicity Biomarkers Era.A Comparative Study of Daily 3-Gy Hypofractionated and 1.8-Gy Conventional Breast Irradiation in Early-Stage Breast Cancer Impact of young age on local control after partial breast irradiation in Japanese patients with early stage breast cancer.

P2860

Q26745834-DA1053BF-0AF9-4708-A7CE-4D9621ED17F0 Q26774616-0D8F8AED-F718-4996-B6C1-978B48B6702F Q30234489-35EF1668-FDEA-4FE0-A820-C805E7E0107C Q36993295-70B06B29-165D-4F6F-BE0A-3711281ACC08 Q38718704-D9A5FB1A-B1A8-4300-BBE6-BF4144178EEE

P2860

Frontiers in radiotherapy for early-stage invasive breast cancer.

http://www.wikidata.org/entity/Q34124291

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Frontiers in radiotherapy for early-stage invasive breast cancer.

@ast

Frontiers in radiotherapy for early-stage invasive breast cancer.

@en

Frontiers in radiotherapy for early-stage invasive breast cancer.

@nl

type

label

Frontiers in radiotherapy for early-stage invasive breast cancer.

@ast

Frontiers in radiotherapy for early-stage invasive breast cancer.

@en

Frontiers in radiotherapy for early-stage invasive breast cancer.

@nl

prefLabel

Frontiers in radiotherapy for early-stage invasive breast cancer.

@ast

Frontiers in radiotherapy for early-stage invasive breast cancer.

@en

Frontiers in radiotherapy for early-stage invasive breast cancer.

@nl

P1433

Q34124291-1522C5DE-69F3-4789-B4C1-F917BF52018F

P1476

Q34124291-3A04F3EA-0D06-476E-AFB4-6FE62510C531

P2093

Q34124291-D61E3A99-718C-4763-8400-9FA080EFFA9E

Q34124291-F808CF85-76A5-40A6-A7C5-A95BDA579DB2

P2860

Q34124291-02B6F8BA-8A86-487F-A603-1EBF6F41B79E

Q34124291-101F089C-CD99-43BA-92A8-5916E22B3F6A

Q34124291-1507277F-A34F-4365-9A00-F6B54BD3A847

Q34124291-2E5CC56C-01A2-4B2B-9FB7-D82FBE70515E

Q34124291-37A44CF8-140F-46A3-AF19-CBD7E3FA11FB

Q34124291-438F41C3-0D67-4B8A-B035-56B219FA690A

Q34124291-4C72E341-4F83-4F35-9F18-BEC6CCC36822

Q34124291-531A22BC-D316-4466-A340-3891F163B660

Q34124291-5395D960-7C3D-435B-A411-07A0E488685D

Q34124291-55186F46-C8B2-415F-B591-548A5C9FADBE

P304

Q34124291-10C85309-7398-4EFB-9AEE-12BC2A8D083E

P31

Q34124291-A1D0902B-6822-4026-93E4-4EAA5CBF77CB

P356

Q34124291-F23F8F9A-79BD-479D-89B3-E8CF83289D81

P407

Q34124291-F0339201-ABE8-4E7C-A992-B869E7567411

P433

Q34124291-0EB7081E-E246-4055-B498-0DAD03B4855C

P478

Q34124291-25CE4207-3BAC-4DAC-BAA3-48772A975E78

P577

Q34124291-D63C9BDB-ADA4-47C4-9E2B-9F20DD4FFFE8

P698

Q34124291-25758383-CEE2-4D5C-896A-5D3C5A961607

P921

Q34124291-92B1DD29-41D7-4C30-8BE2-3DAD96A5A11F

P932

Q34124291-BB8DDE04-5483-41A8-8840-A2017CCAD06C

P356

JCO.2014.55.1184

P1433

Journal of Clinical Oncology

P1476

Frontiers in radiotherapy for early-stage invasive breast cancer.

@en

P2093

Christine M Fisher

http://www.w3.org/2001/XMLSchema#string

Rachel Rabinovitch

http://www.w3.org/2001/XMLSchema#string

P2860

Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial

Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.

Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial.

Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments.

Stereotactic body radiation therapy in multiple organ sites.

Four-week course of radiation for breast cancer using hypofractionated intensity modulated radiation therapy with an incorporated boost.

Phase I-II trial of prone accelerated intensity modulated radiation therapy to the breast to optimally spare normal tissue.

Three-year outcomes of breast intensity-modulated radiation therapy with simultaneous integrated boost.

Hypofractionated breast radiotherapy: financial and economic consequences.

Fractionation for whole breast irradiation: an American Society for Radiation Oncology (ASTRO) evidence-based guideline.

P304

2894-2901

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2014.55.1184

http://www.w3.org/2001/XMLSchema#string

P407

P433

26

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P577

2014-08-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25113764

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

4152718

http://www.w3.org/2001/XMLSchema#string